CKCharis Katsardis

Charis Katsardis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Charis Katsardis has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Exercise‐Induced Dyspnea: There is More to This Than Meets the Eye!—A Narrative Review

    by Maria Michelle Papamichael, Charis Katsardis

    In the sporting community, symptoms of breathlessness during maximal exertion are common complaints in athletes, often mistaken for exercise‐induced asthma and fail to respond to conventional asthma therapy. The possibility of laryngeal abnormalities including exercise‐induced laryngeal obstruction (EILO) as the cause of symptoms is often overlooked due to a lack of clinical insight and awareness of this condition. We aimed to elucidate the relationship between upper airway obstruction at the glottic and supraglottic levels and exercise‐induced dyspnea in recreational and competitive youth athletes. Second, we aimed to gain a broader understanding of the physiologic characteristics' indicative of EILO, its prevalence, and its consequences on athletic performance and diagnostics. A PUBMED search using keywords ‘exercise‐induced asthma or EILO’ was performed to include 21 observational studies of youth athletes with EILO. Overall, the real‐world evidence suggests that complaints of breathlessness, stridor and noisy breathing on inhalation during strenuous exercise are common in youth athletes that are often mistaken for exercise‐induced asthma. Continuous laryngoscopy exercise is the gold standard for identifying laryngeal obstruction in relation to exercise. Glottic or supraglottic closure in response to maximal physical effort are features that differentiate EILO from asthma. Referral to a speech therapist for inspiratory muscle or respiratory retraining is the first line of treatment, and surgery for severe supraglottic dysfunction. In clinical practice, increasing awareness and adopting a systematic multidisciplinary approach investigating respiratory issues in youth athletes and efficient treatment strategies targeting EILO will enable the rapid resolution of symptoms, improve overall patient well‐being, and optimise athletic performance.


  • Open Access

    Prophylactic and therapeutic potential of vitamin D in asthma during the COVID-19 pandemic: the new hope?

    by Maria Michelle Papamichael, Charis Katsardis

    Over the last two decades, the emergence of lethal virulent strains of coronavirus (CoV), including the severe acute respiratory syndrome CoV 2 (SARS-CoV-2), which is responsible for the coronavirus disease 2019 (COVID-19) pandemic, has become a matter of great attention to the scientific community. Despite the implementation of preventive measures throughout the world, the spread of this disease and associated co-morbidities and mortality continue in all countries, continents, and populations of all ages. COVID-19 is highly contagious. Clinical manifestations are diverse and range from asymptomatic, mild to severe, life-threatening complications in the elderly and patients with underlying conditions such as cardiovascular disease, diabetes, obesity, and asthma. In addition, viral infections can trigger asthma attacks. To date, there is no specific treatment schema to combat COVID-19 disease. Current patient care revolves around disease severity and supportive treatment of symptoms from home-rest in mild disease to anti-viral therapy, oxygen support, anti-inflammatories, and anti-coagulants in severe COVID-19. Regarding prevention, the World Health Organization recommends vaccination, social distancing, quarantine, the wearing of surgical masks, and handwashing. In many countries, vaccination is optional, and given that parents are often reluctant to vaccinate themselves and their children for fear of side effects, identifying ways to enhance or support the immune system to prevent infection or improve recovery in vulnerable populations is worth investigating. Furthermore, research has focused on the pharmacological management of COVID-19 symptoms and much less has been published on nutrition therapy. Therefore, the scope of this review is to summarize the latest evidence on the use of vitamin D to support the metabolism and the immune system of asthma patients during the COVID-19 pandemic. A brief overview of asthma and COVID-19 pathophysiology, COVID-19 treatment guidelines for asthma patients, and the role of vitamin D in lung health, including the optimal blood level required to enhance immunity, will be suggested.


  • Nutrient intake, epigenetics, and asthma

    by Maria Michelle Papamichael, Charis Katsardis


  • Open Access

    An exploratory study on the validity and reliability of the Greek translation of Juniper’s Asthma Control Questionnaire in pediatric patients in Greece

    by Maria M. Papamichael, Katrina A. Lambert, Charis Katsardis, Dimitris Tsoukalas, Catherine Itsiopoulos, Bircan Erbas

    Aim: Evaluation of asthma control is the first step in the management of pediatric patient symptoms. The aim of this study was to a) validate the accuracy of the Greek version of the Asthma Contr